Autism on the Rise

The rate of autism is rising. The number of reported cases has increased 10-fold in the last few decades, from 1 in 2,500 in the 1970s to 1 in 250 in the 1990s. Researchers are looking everywhere for the reason--from drinking water to the womb--with no clear-cut answer to date. In part, the increased incidence can be attributed to a broader definition of autism, which now includes milder forms of the disorder,1 as well as to better diagnostics and greater public awareness.2 But scientists don't

Written byLaura Defrancesco
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

At a late-April conference entitled "Autism: Deciphering the Puzzle," developmental biologists, geneticists, and neurobiologists gathered to talk about this complex disease. While scientists attending the conference at the California Institute of Technology could not explain the huge jump in incidence, they did voice some hope: there is progress in understanding the condition's biological basis, along with the development of experimental models, and it could lead to better treatments.

Patricia Rodier, professor of obstetrics and gynecology at the University of Rochester, described an early intervention test at the conference that is used with infants. Devised by Susan Bryson of York University in Toronto, this test measures a child's ability to shift focus from one stimulus to another. In the first part of the test, one light is turned on, and then as a second light is turned on, the first is shut off. All children will shift their focus from the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies